GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment

Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Sagility Ltd
Sagility acquires Chirok Health for up to US$ 32.35 M
M&A ▲ Positive Development MEDIUM RISK
📅 Filed on BSE: 21 Oct 2026, 09:16 PM IST  ·  BSE ID: 16ba48a3-a5c8-4963-9857-443451a512fb
View Original BSE Filing (PDF)
💡
In Simple Terms
Sagility's US subsidiary bought Chirok Health, a healthcare services company, for up to US$ 32.35 M cash.
🤖 AI Summary
  • Sagility (US) Holdings Inc. acquired Chirok Health LLC for an aggregate purchase consideration of up to US$ 32.35 M.
  • The acquisition includes an upfront payment of US$ 20.0 M and contingent consideration up to US$ 12.35 M.
  • Chirok Health LLC, incorporated in 2019, reported a turnover of US$ 9.0 M in CY2025.
  • This acquisition strengthens Sagility's provider segment with specialised Clinical Documentation Integrity (CDI) and medical coding.
  • Sagility will acquire 100% shareholding/control of Chirok Health LLC, with completion on October 21, 2026.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Chirok Health CY2025 Turnover
US$ 9.0 M
Chirok Health CY2024 Turnover
USD 8.2 M
Chirok Health CY2023 Turnover
USD 12.7 M
Aggregate Purchase Consideration
US$ 32.35 M
Upfront Payment at Closing
US$ 20.0 M
Contingent Consideration
US$ 12.35 M
Percentage of Shareholding Acquired
100%
🏢 How This Affects the Company
📈
Business Impact
The acquisition strengthens Sagility's presence in the healthcare provider segment by adding specialized Clinical Documentation Integrity (CDI) and medical coding services, complementing its existing portfolio.
💰
Financial Impact
Sagility will make an upfront cash payment of US$ 20.0 M, with an additional US$ 12.35 M in contingent consideration, impacting cash flow and potentially future earnings through Chirok Health's CY2025 turnover of US$ 9.0 M.
⚙️
Operational Impact
Sagility integrates Chirok Health's US-based team and proprietary CHEMP workflow platform, expanding its service delivery capabilities in healthcare Revenue Cycle Management (RCM).
⚠️
Risk Impact
The contingent consideration up to US$ 12.35 M introduces a performance-based payment structure, linking a portion of the acquisition cost to future operational milestones.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders based on this acquisition announcement.
👤
Who Is Affected
Existing shareholders are indirectly affected as this strategic acquisition influences Sagility Limited's overall business operations and financial structure through its subsidiary, Sagility (US) Holdings Inc.
🔍
Management Signal
This acquisition signals management's intent to accelerate growth in the healthcare provider segment and enhance specialized service offerings.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Q3 FY27 results — monitor financial impact of Chirok Health acquisition.
Future investor calls — look for updates on Chirok Health integration progress.
Subsequent filings — track achievement of performance milestones for contingent consideration.
MEDIUM RISK The acquisition includes contingent consideration, introducing performance-related payment risk.
💡 Investor Takeaway
Sagility completed the 100% acquisition of Chirok Health LLC for an aggregate purchase consideration of up to US$ 32.35 M, with US$ 20.0 M upfront and US$ 12.35 M contingent. Chirok Health recorded US$ 9.0 M turnover in CY2025, enhancing Sagility's healthcare provider capabilities.
⚖️ Strengths & Concerns

✅ Positives

  • Acquisition strengthens Sagility's provider segment by adding specialized Clinical Documentation Integrity (CDI) and medical coding capabilities.
  • Chirok Health LLC brings a CY2025 turnover of US$ 9.0 M, adding to Sagility's existing revenue streams.

⚠️ Concerns

  • The acquisition includes a contingent consideration of up to US$ 12.35 M, dependent on achieving specified performance milestones.
  • Chirok Health's turnover decreased from USD 12.7 M in CY2023 to USD 9.0 M in CY2025, excluding the CY2024 dip.
📅 Company Track Record
Sagility previously acquired CareSeed for up to US$ 30 M in June 2026, which reported CY25 revenue of US$ 5.1 M, aiming to enhance AI-led quality operations and Medicare capabilities. Chirok Health is Sagility's second acquisition in CY26.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What is the total acquisition cost for Sagility's purchase of Chirok Health LLC?
The aggregate purchase consideration for Sagility's acquisition of Chirok Health LLC is up to US$ 32.35 M.
What was Chirok Health LLC's turnover in CY2025?
Chirok Health LLC reported a turnover of US$ 9.0 M in CY2025.
What is the payment structure for the Chirok Health acquisition?
The payment structure includes an upfront payment of US$ 20.0 M at closing and contingent consideration up to US$ 12.35 M.
What services does Chirok Health LLC provide?
Chirok Health LLC provides Clinical Documentation Integrity (CDI), medical coding, Revenue Cycle Management (RCM), and audit and quality assurance services.
When was Chirok Health LLC incorporated?
Chirok Health LLC was incorporated in 2019 and is headquartered in Tennessee, United States.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.